This bill would exempt from New Jersey's sales and use tax the purchase of rapid or laboratory viral tests (including molecular and antigen tests) and antibody tests used to detect infections like SARS-CoV-2. It directly affects consumers and businesses buying these specific medical tests for infection screening. The exemption applies to sales occurring after the bill's effective date, removing a cost barrier for these diagnostic tools. This policy change aims to make infection testing more affordable by eliminating state sales tax on qualifying tests.
This bill requires New Jersey's State veterans' memorial homes to maintain minimum direct care staff-to-resident ratios based on resident needs and facility size. The Division of Veterans’ Healthcare Services must establish these ratios, review them quarterly, and ensure each home meets the set standard. "Direct care staff" includes registered nurses, licensed practical nurses, and certified nurse aides working within their scope. The bill does not override existing health department or federal staffing rules for non-direct care staff and allows homes to exceed minimum staffing levels at any time.
This bill establishes the "New Jersey COVID-19 Long-Term Health Effects Task Force" to study and address ongoing health impacts of the pandemic. The task force will identify symptoms, treatments, and vaccine-related health effects, develop public education strategies, and create guidance for healthcare providers treating affected patients. It requires a nine-member group including health officials, medical experts, and public appointees from legislative leaders, with the Department of Health providing administrative support. The task force must submit a final report with recommendations within one year of forming and will expire 30 days after that submission. This directly affects New Jersey residents experiencing long-term COVID-19 symptoms and the state's healthcare system.
This bill requires New Jersey nursing homes to submit their most recent federal Medicare/Medicaid cost reports as part of their annual financial filings with the Department of Health, due within 90 days after their fiscal year ends. It also mandates detailed ownership disclosures for all owners (revising the prior 10% threshold to any ownership interest) and requires the Department to compile aggregated spending data - without naming specific facilities - into an annual public report published online. The report will include regional and county expenditure totals across categories like staffing and supplies. This amends existing annual reporting rules to add federal cost report requirements and enhance transparency around nursing home ownership and spending.
This New Jersey bill allows eligible residents to deduct 50% of out-of-pocket expenses for in vitro fertilization (IVF) treatment from their gross income when filing state taxes. It directly affects individuals or couples paying for IVF who are not covered by specific health insurance plans (including state programs like the State Health Benefits Program) and whose expenses aren't already deductible as medical costs. The deduction applies to costs for the taxpayer, spouse, or domestic partner, but excludes amounts reimbursed by insurance or already claimed under existing medical expense deductions. The law takes effect immediately for tax years beginning after its enactment.
This bill prohibits all New Jersey public and private schools, as well as state, county, and local government entities, from requiring influenza vaccinations or any other flu immunity procedure for individuals under 18 years old. It explicitly bans both direct and indirect requirements for flu shots or related medications for this age group. The law takes immediate effect upon passage and applies to all government employees, officials, and school settings. This policy change directly affects minors enrolled in schools or interacting with government services by removing mandatory flu vaccination requirements.
This bill, S 3666, expands New Jersey's Primary Care Practitioner Loan Redemption Program to include physical therapists as eligible participants. Currently, the program helps healthcare professionals like doctors, dentists, and nurse practitioners reduce student loan debt by working in underserved areas, but physical therapists were previously excluded. The bill amends eligibility requirements to explicitly add "physical therapist" to the list of qualifying professionals under the program. This change allows physical therapists working in designated underserved areas to access the same loan redemption benefits - up to $120,000 in repayment - without altering existing program rules like the service location requirements or funding limits.
This bill establishes a nine-member task force within New Jersey's Department of Health to study health care access barriers faced by LGBTQI residents (lesbian, gay, bisexual, transgender, queer/questioning, and intersex individuals). The task force will examine current policies, health care resources, medical training, and barriers like discrimination or lack of insurance coverage. It must make recommendations to improve health care quality and accessibility for this community within one year. The bill directly affects LGBTQI New Jersey residents by addressing documented health disparities they experience.
This bill streamlines EMT-Basic certification in New Jersey for veterans who served as Combat Army Medics or Navy Hospital Corpsmen (or equivalent roles). It allows eligible veterans to bypass standard training requirements if they hold a current National Registry of Emergency Medical Technicians (NREMT) certification, have served in those specific military roles, and pass a background check. The bill also requires the Department of Health to publish clear online guidance about these streamlined requirements. This directly affects honorably discharged veterans with qualifying military medical experience seeking EMT certification.
This New Jersey bill requires pharmacy benefits managers (PBMs) to disclose pricing methodologies in contracts, including whether they use different pricing lists for retail versus mail-order drugs, and to provide a toll-free line for consumers to speak with a New Jersey-licensed pharmacist about drug pricing issues within 24 hours. It establishes a Prescription Drug Review Commission to identify critical prescription drugs (based on factors like cost to public health programs and treatment effectiveness) and monitor their pricing. These measures aim to increase transparency in drug pricing and reduce costs for essential medications, directly affecting PBMs and the state's Division of Consumer Affairs.
